WT1 and acute myeloid leukemia: For this purpose, we designed an NGS-based DNA methylation panel comprising of genes previously published as having an impact on AML outcome, altogether with genes generally involved in AML pathogenesis (WT1 and HOX genes), and genes that emerged from our unpublished research to evaluate their collective influence on AML prognosis.